Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

Ver Investigador - - Prisma - Unidad de Bibliometría

Ildefonso Espigado Tocino

Profesor Titular de Universidad (Pza. V)
espigado@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin grupo
Prog. doctorado: BIOLOGÍA MOLECULAR, BIOMEDICINA E INVESTIGACIÓN CLÍNICA

Investiga en

Palabras clave
Líneas de investigación
Resumen
Tipo Año Título Fuente
Artículo2024 Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 EClinicalMedicine
Letter2024 Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry HAEMATOLOGICA
Corrección2024 Erratum: Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey (Infection (2024) 52 3 (1125-1141)) INFECTION
Artículo2024 Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists CLIMACTERIC
Artículo2024 Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey INFECTION
Artículo2024 Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial BONE MARROW TRANSPLANTATION
Artículo2024 Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain Transplantation and Cellular Therapy
Artículo2024 Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry HEMATOLOGICAL ONCOLOGY
Artículo2024 The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey LEUKEMIA & LYMPHOMA
Artículo2024 Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC) MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
Artículo2023 Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2023 COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) HAEMATOLOGICA
Artículo2023 Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey Blood Advances
Artículo2023 Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Artículo2023 Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry EClinicalMedicine
Artículo2023 One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients BLOOD CANCER JOURNAL
Artículo2023 Outcome of COVID-19 in allogeneic stem cell transplant recipients: results from the EPICOVIDEHA registry FRONTIERS IN IMMUNOLOGY
Artículo2023 Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry THERAPEUTIC ADVANCES IN HEMATOLOGY
Artículo2022 Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey BLOOD
Artículo2022 COVID-19 and CAR T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP Blood Advances
Letter2022 Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report HemaSphere
Artículo2022 Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience STEM CELLS TRANSLATIONAL MEDICINE
Artículo2022 SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group AMERICAN JOURNAL OF HEMATOLOGY
Artículo2022 SF3B1, RUNX1 and TP53 mutations significantly impact the outcome of patients with lower-risk myelodysplastic syndrome CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2021 Allogeneic hematopoietic stem cell transplant recipients in Spain: human leukocyte antigen characteristics and diversity by high-resolution analysis HLA
Artículo2021 Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: a multicenter study from the Spanish hematopoietic transplantation and cell therapy group TRANSPLANT INFECTIOUS DISEASE
Artículo2021 Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment BONE MARROW TRANSPLANTATION
Artículo2021 COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Journal of Hematology and Oncology
Artículo2021 Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group AMERICAN JOURNAL OF TRANSPLANTATION
Artículo2021 Defibrotide in hematopoietic stem cell transplantation: a multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH) EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2021 Long-term impact of an educational antimicrobial stewardship program on management of patients with hematological diseases Antibiotics
Letter2021 T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients HAEMATOLOGICA
Artículo2020 Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study BMJ OPEN
Artículo2020 Risk factors and outcome of COVID-19 in patients with hematological malignancies EXPERIMENTAL HEMATOLGY & ONCOLOGY
Artículo2020 Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study BONE MARROW TRANSPLANTATION
Artículo2019 Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Resumen congreso2019 Influence of basic parameters of hemostasis in the hemorrhagic profile of the chronic PTI HAEMATOLOGICA
Resumen congreso2019 Mucormycosis in oncohematological patients and recipients of hematopoietic progenitor transplantation. Experience of a center in fourteen years HAEMATOLOGICA
Resumen congreso2019 Mutational profile in patients with low-risk myelodysplastic syndrome at the time of progression to acute leukemia HAEMATOLOGICA
Resumen congreso2019 Safety and efficacy of the BCR inhibitors after allogeneic stem cell transplantation for CLL BONE MARROW TRANSPLANTATION
Resumen congreso2019 Sequential cumulative effect on the alfa diversity of the intestinal microbiota of honey-binding conditions and active antibiotics against gram-negatives HAEMATOLOGICA
Artículo2019 Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of the Spanish group of hematopoietic stem cell transplant BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2018 A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms Blood Advances
Resumen congreso2018 European Myeloma Network phase I trial on RIC allogeneic transplantation: an optimized program for high risk relapsed myeloma patients BONE MARROW TRANSPLANTATION
Artículo2018 Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndrome CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2018 FOUR CASES OF MYELOID NEOPLASM RELATED TO THERAPEUTICS IN THE CONTEXT OF TREATMENT OF SARCOMAS IN FLABBY PARTS HAEMATOLOGICA
Resumen congreso2018 Hematopoietic Stem cell transplant in Aplastic anemia in patients older than 40 years: the experience of the Spanish Group of Hematopoietic Stem Cell Transplant (GETH) BONE MARROW TRANSPLANTATION
Resumen congreso2018 IBRUTINIB - RELATED TOXICITY AND SUSPENSION OF TREATMENT HAEMATOLOGICA
Resumen congreso2018 Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia BLOOD
Resumen congreso2018 PROGNOSTIC VALUE OF PRE-ALOTPH EMR IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA HAEMATOLOGICA
Resumen congreso2018 RATIO OF ABSOLUTE CIRCULATING LYMPHOCYTES/MONOCYTES AS A PROGNOSTIC FACTOR IN THE DLCL-B TO DIAGNOSIS HAEMATOLOGICA
Resumen congreso2018 RESULTS OF TREATMENT GUIDED BY PET/INTERMEDIATE TAC IN PATIENTS WITH DIAGNOSIS OF LYMPHOMA B DIFFUSE OF LARGE CELLS (LBDCG). EXPERIENCE OF A CENTER HAEMATOLOGICA
Resumen congreso2018 Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH) BLOOD
Resumen congreso2018 USE OF SORAFENIB IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA FLT3-ITD POSITIVE IN SITUATION OF RELAPSE OR REFRACTORINESS: RECENT EXPERIENCE OF A CENTER HAEMATOLOGICA
Resumen congreso2018 WHAT CAN WE CONCLUDE FROM RUXOLITINIB AFTER MORE THAN 5 YEARS OF EXPERIENCE WITH THE DRUG? HAEMATOLOGICA
Resumen congreso2017 A multicenter randomized clinical trial evaluating the safety and feasibility of the treatment of GVHD with allogenic mesenchymal stem cells (MSC) from adipose tissue CYTOTHERAPY
Artículo2017 Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study CYTOTHERAPY
Resumen congreso2017 ANAGRELIDE RESPONSE ACCORDING TO THE MOLECULAR PROFILE: SOMETHING TO CONCLUDE ON THE MECHANISM OF ACTION OF THE DRUG IN MYELOPROLIFERATIVE NEOPLASMS (MPN)? HAEMATOLOGICA
Resumen congreso2017 ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH MYELODISPLASIC SYNDROME SUBJECTED TO ALOGENIC TRANSPLANT OF HEMATOPOYETIC PROGENITORS HAEMATOLOGICA
Resumen congreso2017 Analysis of the incidence and causes of admission in the icu in large cohort of adult patients subjected to hematopoyetic transplantation HAEMATOLOGICA
Resumen congreso2017 ASSESSING PROGNOSIS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES. PARAMETERS RELATED TO THE PROBABILITY OF LEUKEMIC PROGRESSION LEUKEMIA RESEARCH
Artículo2017 Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR) BMJ OPEN
Resumen congreso2017 Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression BLOOD
Resumen congreso2017 DISCONTINUING ANTIBACTERIAL THERAPY AFTER APYREXIA AND CLINICAL STABILITY REGARDLESS OF NEUTROPHIL COUNT IN FEBRIL NEUTROPENIA IS SAFE AND REDUCES EXPOSITION TO ANTIBIOTICS (HOWLONG RANDOMIZED TRIAL) HAEMATOLOGICA
Artículo2017 Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Resumen congreso2017 EUROPEAN MYELOMA NETWORK CLINICAL TRIAL PHASE I (ALLO-EMN) OF ALLOGENIC TRANSPLANTATION IN PATIENTS WITH HIGH RISK MULTIPLE MYELOMA (MM) HAEMATOLOGICA
Resumen congreso2017 Improvement of outcome after autologous stem cell transplantation by reduction of infections and SOS/VOD syndrome's related mortality: 28 years single-center experience BONE MARROW TRANSPLANTATION
Resumen congreso2017 Is idiopathic myelofibrosis (MFI) with V617 JAK2 mutation is the same entity as secondary myelofibrosis (MFS) to evolution of mutated myeloproliferative neoplasm (MPN)? HAEMATOLOGICA
Artículo2017 Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2017 MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS AND TRANSPLANT RECIPIENTS OF HEMATOPOIETIC PROGENITORS HAEMATOLOGICA
Resumen congreso2017 MULTICENTRIC STUDY ON THE USE OF RUXOLITINIB IN ACUTE AND REFRACTORY CHRONIC EICH IN ONE OR MORE TREATMENT LINES. RESULTS OF OUR EXPERIENCE HAEMATOLOGICA
Artículo2017 Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial LANCET HAEMATOLOGY
Artículo2017 Posicionamiento y actitudes de manejo sobre la profilaxis antifúngica en el paciente hematológico (proyecto PROMIC) Revista Española de Quimioterapia
Resumen congreso2017 Prognostic evaluation in patients with low risk myelodysplastic syndrome parameters related to the probability of leukemic progression HAEMATOLOGICA
Resumen congreso2017 Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm BLOOD
Resumen congreso2017 THE 1RC STATUS AND THE NEW DIAGNOSIS ARE ASSOCIATED WITH BETTER LONG-TERM SURVIVAL IN ALLOTRANSPLANTED PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA HAEMATOLOGICA
Resumen congreso2017 THE COMBINED TREATMENT WITH AAS AND HEPARIN OF LOW MOLECULAR WEIGHT IS EFFECTIVE IN THE PREVENTION OF THROMBOSIS IN PREGNANT WOMEN WITH MYELOPROLIFERATIVE NEOPLASMS HAEMATOLOGICA
Artículo2017 The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome LEUKEMIA & LYMPHOMA
Resumen congreso2017 THE PROBABILITY OF CONCLUDING ALLOGENIC TRANSPLANTATION FROM ITS INDICATION IS SIMILAR TO HAVING OR NOT HAVING HISTOCOMPATIBLE SIBLING: SELECTION STRATEGY BASED ON THE PREFERENTIAL USE OF UNRELATED DONOR (ND) AS AN ALTERNATIVE SOURCE OF HAEMATOPOIETIC PROGENITORS (HP) HAEMATOLOGICA
Resumen congreso2017 TO SUSPEND THE EMPIRICAL ANTIMICROBIAL TREATMENT AFTER THREE DAYS OF APYREXIA IN HEMATOLOGICAL PATIENTS WITH FEBRILE NEUTROPENIA IS SAFE AND REDUCES UNNECESSARY EXPOSURE TO ANTIBIOTICS: FINAL RESULTS OF THE RANDOMIZED CLINICAL TRIAL HOW LONG HAEMATOLOGICA
Resumen congreso2016 A novel genetic and clinical predictive model for severe acute and chronic graft versus host disease after identical HLA-allogeneic stem-cell transplantation BONE MARROW TRANSPLANTATION
Letter2016 Differences in stem cell transplantation activity among regions in Spain: an economic explanation BONE MARROW TRANSPLANTATION
Artículo2016 Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Espanol de Trasplante Hematopoyetico BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Letter2016 Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2016 Survival and long-term complications of receptors of hematopoietic progenitor transplantation HAEMATOLOGICA
Resumen congreso2016 THE INCORPORATION OF COMORBIDITIES IN THE PROGNOSTICATION OF PATIENTS WITH LOWER-RISK MDS HAEMATOLOGICA
Resumen congreso2015 A new multiple single-nucleotide polymorphisms based predictive model for grades III to IV and extensive graft versus host disease after identical HLA-allogeneic stem-cell BLOOD
Resumen congreso2015 A new predictive model based on the genomic profile of polymorphisms in genes of cytokines allows to predict the incidence of post-transplant EICR allogeneic hematopoietic HAEMATOLOGICA
Artículo2015 Acute myeloid leukemia 7 years after aleukemic leukemia cutis INTERNATIONAL JOURNAL OF DERMATOLOGY
Resumen congreso2015 After admission to intensive care unit non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplantation HAEMATOLOGICA
Artículo2015 Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party LEUKEMIA
Resumen congreso2015 Characteristics of oncohematological patients admitted in the intensive care unit (uci): comparision between the patients subjected to transplant of hematopoietic progenitors and non transplantation (no-tph) HAEMATOLOGICA
Artículo2015 Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time BONE MARROW TRANSPLANTATION
Resumen congreso2015 IMPLICATIONES OF THE ADVERSE KARYOTYPE IN PATIENTS WITH MYELODYSPPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA. EXPERIENCE OF A CENTRE HAEMATOLOGICA
Artículo2015 Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure TRANSFUSION
Artículo2015 Mortality of Oncohematological Patients Undergoing Hematopoietic Stem Cell Transplantation Admitted to the Intensive Care Unit TRANSPLANTATION PROCEEDINGS
Resumen congreso2015 MUCORMYCOSIS IN ONCOHAEMATOLOGICAL PATIENTS AND RECEPTORS OF TRASPLANTS OF HAEMOTOPOIETIC PROGENITORS. EXPERIENCE OF THE LAST 10 YEARS OF A SINGLE CENTRE HAEMATOLOGICA
Artículo2015 Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2015 Productivity loss due to premature mortality caused by blood cancer: a study based on patients undergoing stem cell transplantation GACETA SANITARIA
Resumen congreso2015 PROGNOSTIC VALUE OF THE EVALUATION OF THE PRETRANSPLANT ALLOGENEIC CARDIAC FUNCTION HAEMATOLOGICA
Resumen congreso2015 Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation BLOOD
Artículo2015 Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2015 Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma HEMATOLOGICAL ONCOLOGY
Resumen congreso2015 THE ADDITION OF COMORBIDITY ALLOWS A BETTER STRATIFICATION AND DEVELOPMENT OF A SPECIFIC PROGNOSTIC SCORE IN THE GROUP OF PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW RISK BY IPSS HAEMATOLOGICA
Artículo2015 The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation PLOS ONE
Resumen congreso2015 THE INVASIVE FUNGAL INFECTION IS A CLINICALLY RELEVANT CAUSE OF MORTALITY AND MORBIDITY IN PATIENTS WITH LYMPHOPROLIFERATIVE SYNDROMES HAEMATOLOGICA
Artículo2014 Antifungal Combination Therapy for Invasive Aspergillosis CLINICAL INFECTIOUS DISEASES
Resumen congreso2014 AZACITIDINE IMPROVES SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES WITH 20-30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETIC CATEGOR HAEMATOLOGICA
Resumen congreso2014 Donor and recipient genotypes for interleukin 1 gene single nucleotide polymorphisms (SNPs) allow anticipation of acute graft versus host disease after HLA-identical allogeneic stem cell transplantation (allo-SCT) BLOOD
Artículo2014 Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2014 Infección nosocomial asociada al catéter venoso central en pacientes con Trasplante de Progenitores Hematopoyéticos Evidentia: Revista de enfermería basada en la evidencia
Artículo2014 Intra-Arterial Bone Marrow Mononuclear Cell Transplantation Correlates With GM-CSF, PDGF-BB, and MMP-2 Serum Levels in Stroke Patients: Results From a Clinical Trial Cell Transplantation
Artículo2014 Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014 Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2014 Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients BLOOD
Resumen congreso2014 Single nucleotide polymorphisms (SNPS) in interleukin 1A and 1B genes associate with patient susceptibility to complications after HLA-identical sibling allo-SCT. BONE MARROW TRANSPLANTATION
Resumen congreso2014 SNPs in the promoter region of the IL17A gene allow anticipation of complications after sibling HLA-identical allogeneic stem cell transplantation (allo-SCT) BONE MARROW TRANSPLANTATION
Artículo2014 Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation TRANSPLANT INTERNATIONAL
Artículo2013 A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT BONE MARROW TRANSPLANTATION
Resumen congreso2013 Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation BLOOD
Artículo2013 Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2013 Cost-Effectiveness Analysis Comparing Two Approaches for Empirical Antifungal Therapy in Hematological Patients with Persistent Febrile Neutropenia ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Resumen congreso2013 EARLY DETECTION OF SERUM GALACTOMANNAN ANTIGEN IN HEMATOLOGIC MALIGNANCIES: IMPACT OF A LABORATORY ASSAY IN ASPERGILLUS INFECTION MORTALITY RATE HAEMATOLOGICA
Resumen congreso2013 Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma BLOOD
Resumen congreso2013 GSTT1 mismatch constitutes a risk factor for acute and chronic hepatic GVHD and influences patient survival BONE MARROW TRANSPLANTATION
Resumen congreso2013 Higher-risk myelodysplastic syndromes. Does the severity of cytopenias at diagnosis have any prognostic significance? LEUKEMIA RESEARCH
Artículo2013 Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy TRANSPLANTATION PROCEEDINGS
Artículo2013 Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors TRANSFUSION
Resumen congreso2013 Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals BLOOD
Resumen congreso2013 Mobilization Scheme With Cytarabine In Poor Mobilizers Patients Diagnosed With Lymphoma BLOOD
Resumen congreso2013 Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score BLOOD
Resumen congreso2013 Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell BLOOD
Resumen congreso2013 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis LEUKEMIA RESEARCH
Letter2013 Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/sezary syndrome BRITISH JOURNAL OF HAEMATOLOGY
Artículo2013 To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2012 A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT BONE MARROW TRANSPLANTATION
Resumen congreso2012 A gene variant in IRF3 impacts on the clinical outcome of Acute Myeloid Leukemia (AML) patients submitted to allogeneic Stem Cell Transplantation (allo-SCT) BLOOD
Resumen congreso2012 Clinical prognostic factors for myelodysplastic syndromes presenting non-unfavourable cytogenetic categories according to IPSS and the new cytogenetic prognostic scoring system HAEMATOLOGICA
Artículo2012 Comparación de dos estrategias iniciales de movilización de progenitores hematopoyéticos de sangre periférica para trasplante autogénico en pacientes con linfomas e infección por el virus de la inmunodeficiencia humana MEDICINA CLINICA
Resumen congreso2012 Impact of V617F mutation in the management of thrombotic risk in patients with essential thrombocytemia HAEMATOLOGICA
Resumen congreso2012 Increased Gene Expression Involved in Angiogenesis, Metabolism and Cell Proliferation in Acute Myeloid Leukemia and myelodysplastic Syndromes Correlates with Adverse Clinical and Biological Features BLOOD
Artículo2012 Intra-Arterial Bone Marrow Mononuclear Cells in Ischemic Stroke A Pilot Clinical Trial STROKE
Artículo2012 Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy BONE MARROW TRANSPLANTATION
Resumen congreso2012 Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis BLOOD
Resumen congreso2012 To freeze or not to freeze haematopoietic stem cells prior to allogeneic transplantation BONE MARROW TRANSPLANTATION
Artículo2012 Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach HAEMATOLOGICA
Resumen congreso2011 -52G/A Gene Variant in the beta-Defensin-1 (DEBF1) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response BLOOD
Resumen congreso2011 A Recessive Gene Variant in TGFBI in the Donor Influences the Acute Graft Versus Host Disease Development and Impacts in the Outcome After Allogeneic Stem Cell Transplantation (Allo-SCT) BLOOD
Resumen congreso2011 G to C Transition At Position-173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT) BLOOD
Artículo2011 Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34(+) cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors HAEMATOLOGICA
Artículo2011 Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease IMMUNOLOGY LETTERS
Resumen congreso2011 Outcome of pandemic H1N1 infections in haematopoietic stem cell transplant recipients BONE MARROW TRANSPLANTATION
Artículo2011 Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients HAEMATOLOGICA
Resumen congreso2011 Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT BLOOD
Artículo2011 Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study CLINICAL TRANSPLANTATION
Resumen congreso2011 Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System BLOOD
Artículo2011 Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients CLINICAL TRANSPLANTATION
Resumen congreso2011 The Genotype in the Donor and Recipient for the Polymorphim-174 G/C of the IL-6 Influences the Outcome of HLA-Identical Related Stem Cell Transplantation BLOOD
Resumen congreso2011 The presence of allele G in the donor for the polymorphism A7488G of the IL-17 gene improves relapse rate and survival after HLA-identical related stem cell transplantation BONE MARROW TRANSPLANTATION
Artículo2011 Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients ANTIVIRAL THERAPY
Capítulo2010 Autotrasplante de progenitores hematopoyéticos en pacientes pediátricos diagnosticados de Sarcoma de Ewing óseo: Indicaciones y resultados Actualizaciones en trasplantes 2010
Resumen congreso2010 BCR-ABL SEQUENCING AND MUTATIONAL STATUS IN CHRONIC MYELOID LEUKEMIA: DESCRIPTION OF ATYPICAL MUTATIONS AND RELATIONSHIP WITH RESPONSE TO IMATINIB AS A PRELIMINARY ANALYSIS OF A SINGLE CENTER STUDY HAEMATOLOGICA
Artículo2010 Clinical Utility of Real-Time Polymerase Chain Reaction to Quantify Cytomegalovirus Replication in Allogeneic Stem Cell Transplant Recipients With Different Prevention Strategies TRANSPLANTATION PROCEEDINGS
Resumen congreso2010 Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anaemia BONE MARROW TRANSPLANTATION
Resumen congreso2010 Constitutional variability in genes involved in innate immunity (IRF-3, HAMP, PTX3) and in cell proliferation (ATBF1 and NFAT5) influences disease free survival after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2010 CONSTITUTIONAL VARIABILITY IN GENES INVOLVED IN INNATE IMMUNITY AND IN CELL PROLIFERATION INFLUENCES DISEASE FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION HAEMATOLOGICA
Resumen congreso2010 Cytomegalovirus Specific Immunity Protects From Cytomegalovirus Replication After Hematopoietic Stem Cell Transplantation BLOOD
Artículo2010 Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays JOURNAL OF CLINICAL VIROLOGY
Resumen congreso2010 Differences in cytomegalovirus replication quantified by quantitative PCR and antigenemia pp-65 after allogeneic stem cell transplantation with different prevention strategies BONE MARROW TRANSPLANTATION
Artículo2010 Differences in Cytomegalovirus Replication Quantified Using Quantitative Polymerase Chain Reaction and Antigenemia After Allogeneic Stem Cell Transplantation TRANSPLANTATION PROCEEDINGS
Resumen congreso2010 Effect of glutathione S-transferase T1 mismatch in hepatic graft versus host disease after allogenic hemopoietic stem cell transplantation TISSUE ANTIGENS
Capítulo2010 El Programa de trasplante de progenitores hematoyéticos del Hospital Universitario Virgen del Rocío en el contexto español. Año 2009 Actualizaciones en trasplantes 2010
Artículo2010 Empirical antifungal therapy in selected patients with persistent febrile neutropenia BONE MARROW TRANSPLANTATION
Resumen congreso2010 Genetic mismatch in GSTT1 is associated with hepatic acute graft-versus-host disease in allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2010 Genetic Variability In the Transcriptional Factor EP300 Strongly Influences the Clinical Outcome of Allogeneic Stem Cell Transplantation (Allo-SCT) BLOOD
Letter2010 Glutathione S-transferase T1 is a potential new target for the hepatic component of graft vs host disease after HSCT BONE MARROW TRANSPLANTATION
Resumen congreso2010 Glutathione S-Transferase T1 Mismatch and Presence of Anti-GSTT1 Antibodies In Hepatic Gvhd BLOOD
Resumen congreso2010 How organizational pre-transplant measures may improve clinical outcomes in haemopoietic stem cell transplantation BONE MARROW TRANSPLANTATION
Ponencia2010 Indication of empirical antifungal therapy in selected patients with persistent febrile neutropenia according to clinical criteria and risk profile BONE MARROW TRANSPLANTATION
Resumen congreso2010 Influenza A (H1N1) Virus Infection in Hematologic patients In The South And West Of Spain BLOOD
Resumen congreso2010 Long-term follow-up of autologous stem cell transplant in AIDS-related Lymphoma patients. Results of Spanish Cooperative Registry GELTAMO/GESIDA BONE MARROW TRANSPLANTATION
Resumen congreso2010 Minimal residual disease post-consolidation therapy affects outcome after stem cell transplantation in acute myeloid leukaemia BONE MARROW TRANSPLANTATION
Resumen congreso2010 MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS (PBSC) FOR AUTOLOGOUS STEM CELLTRANSPLANTATION (ASCT) IN PATIENTS WITH LYMPHOMA AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION HAEMATOLOGICA
Resumen congreso2010 Pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation guided by quantitative real time-PCR BONE MARROW TRANSPLANTATION
Artículo2010 Role of Second Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Hematologic Malignancies TRANSPLANTATION PROCEEDINGS
Capítulo2010 Sistematización de la etapa pre-trasplante hematopoyético como herramienta de mejora de los resultados clínicos Actualizaciones en trasplantes 2010
Resumen congreso2010 The Genotype of the Donor for the Polymorphism A7488G of the IL-17 Gene Influences relapse and survival After HLA-Identical Related Stem Cell Transplantation. BLOOD
Artículo2010 Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Resumen congreso2010 VCAM1 RS1041163 POLYMORPHISM INFLUENCES G-CSF MOBILIZATION OF CD34+CELLS HAEMATOLOGICA
Resumen congreso2009 Association of CXCL12, VCAM1 and CD34 gene polymorphisms with peripheral blood progenitor cell mobilisation in healthy donors BONE MARROW TRANSPLANTATION
Artículo2009 Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma JOURNAL OF CLINICAL ONCOLOGY
Corrección2009 Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma (vol 27, pg 2192, 2009) JOURNAL OF CLINICAL ONCOLOGY
Resumen congreso2009 Catheter-related infections in tunnelled central venous devices in haematologic malignancies and haematopoietic stem cell transplantation patients. A single-centre experience BONE MARROW TRANSPLANTATION
Artículo2009 Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation BLOOD
Resumen congreso2009 COMPARISON BETWEEN LYMPHOGLOBULINE- AND THYMOGLOBULINE-BASED IMMUNOSUPPRESSIVE THERAPY AS FIRST-LINE TREATMENT FOR PATIENTS WITH APLASTIC ANEMIA HAEMATOLOGICA
Resumen congreso2009 Comparison Between Lymphoglobuline- and Thymoglobuline-Based Immunosuppressive Therapy as First-Line Treatment for Patients with Aplastic Anemia. BLOOD
Resumen congreso2009 CXCL12 RS1801157 POLIMORPHISM IS ASSOCIATED WITH DECREASED MRNA CXCL12 EXPRESSION AND HIGHER HEMOPOIETIC PROGENITOR CELL MOBILIZATION HAEMATOLOGICA
Resumen congreso2009 Donor's Genetic Variability in NFAT5 and ATBF1, Transcriptional Factors Involved in Cellular Growth and Proliferation, Are Prognostic Factors for Disease Free Survival After Allogeneic Stem Cell Transplantation (Allo-SCT) BLOOD
Capítulo2009 Evaluación de la etapa pre-trasplante hematopoyético en pacientes con leucemia aguda. Actualizaciones en trasplantes 2009
Capítulo2009 Evaluación de la infección por citomegalovirus tras el trasplante Actualizaciones en trasplantes 2009
Resumen congreso2009 Hickman catheter-associated infections after haematopoietic stem cell transplantation and their relationship with period elapsing from catheter implantation to transplantation BONE MARROW TRANSPLANTATION
Capítulo2009 Infecciones relacionadas con catéteres venosos centrales permanentes en el Trasplante de Progenitores Hematopoyéticos y hemopatías malignas. Estudio descriptivo Actualizaciones en trasplantes 2009
Artículo2009 Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study HAEMATOLOGICA
Resumen congreso2009 Long-Term Follow-up of HCV Infected Stem Cell Transplant Patients and Effects of Antiviral Therapy. BLOOD
Resumen congreso2009 Low-Intensity Fludarabine, Cyclophosphamyde, Rituximab (FCR) as Front-Line Treatment for Follicular Lymphoma. Efficacy and Toxicity Profile of the Oral Versus Intravenous Administration BLOOD
Resumen congreso2009 PO-065 Valor pronóstico de la enfermedad mínima residual previa al trasplante de progenitores hemopoyéticos en pacientes con leucemia mieloide aguda HAEMATOLOGICA
Resumen congreso2009 Predictive factors for relapse in adult patients with high-risk acute lymphoblastic leukaemia submitted to an unrelated haematopoietic progenitor transplant BONE MARROW TRANSPLANTATION
Capítulo2009 Programa de trasplante de progenitores hematopoyéticos de los HH UU Virgen del ROCÍO en 2008 Actualizaciones en trasplantes 2009
Resumen congreso2009 Reasons why acute leukaemia patients with established indication for stem cell transplantation do not finally undergo the procedure and its clinical consequences BONE MARROW TRANSPLANTATION
Capítulo2009 Replicación viral de CMV medida mediante PCR a tiempo real y antigenemia pp-65 tras el Trasplante Hematopoyético Alogénico (ALO-TPH) Actualizaciones en trasplantes 2009
Resumen congreso2009 Results of reduced-intensity conditioning stem cell transplantation with intensified fludarabine-based regimen for advanced lymphoid malignancies BONE MARROW TRANSPLANTATION
Artículo2009 Risk score for outcome after allogeneic hematopoietic stem cell transplantation a retrospective analysis CANCER
Capítulo2009 Trasplante alogénico de progenitores hemopoyéticos con acondicionamiento de intensidad reducida en pacientes con neoplasias linfoides. Nuestra experiencia Actualizaciones en trasplantes 2009
Editorial2008 Coste-efectividad del tratamiento antifúngico empírico de pacientes hematológicos con alto riesgo de infección fúngica invasora FARMACIA HOSPITALARIA
Artículo2008 Evaluación de la reactivación de citomegalovirus tras el trasplante METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Artículo2008 Evaluation of the Pretransplantation Phase of the Hemopoietic Stem Cell Program in a Tertiary Hospital TRANSPLANTATION PROCEEDINGS
Ponencia2008 Gestión electrónica del programa de trasplante hemopoyético ¿Por qué algunos candidatos no llegan a trasplantarse? Eliminando las barreras del conocimiento: XII Encuento Internacional de Investigación en Enfermería conjuntamente con 6º Coloquio Bianual Joanna Briggs Córdoba, Spain 12-15 Noviembre 2008
Artículo2008 High Rate of Long-Term Survival for High-Risk Lymphoma Patients Treated With Hematopoietic Stem Cell Transplantation as Consolidation or Salvage Therapy TRANSPLANTATION PROCEEDINGS
Resumen congreso2008 Long-term follow-up of HCV infected patients; Updated results of the EBMT prospective study INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2008 Preemptive Therapy for Cytomegalovirus Disease in Allogeneic Stem Cell Transplant Recipients TRANSPLANTATION PROCEEDINGS
Resumen congreso2008 The efficacy of a single dose pegfilgrastim following myeloablative chemotherapy for stem cell mobilisation in patients with solid tumours and lymphomas BONE MARROW TRANSPLANTATION
Resumen congreso2008 The role of reduced-intensity allogeneic stem cell transplantation in patients with advanced acute myeloid leukaemia and myelodysplastic syndromes BONE MARROW TRANSPLANTATION
Resumen congreso2008 UNRELATED TRANSPLANTS FOR POOR PROGNOSIS ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: LONG-TERM COMPARATIVE ANALYSIS BASED ON THE HEMATOPOIETIC PROGENITOR SOURCE HAEMATOLOGICA
Resumen congreso2008 Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source. BLOOD
Resumen congreso2007 Autologous stem cell transplantation (ASCT) in HIV associated lymphoma (HIV-Ly) patients: An updated analysis of the EBMT lymphoma working party (EBMT-LWP) experience. BLOOD
Resumen congreso2007 Comparable survival between HIV plus and HIV-Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) patients undergoing an autologous peripheral blood stem cell transplantation (ASCT). A retrospective analysis of the EBMT lymphoma working party BLOOD
Resumen congreso2007 Comparison of PCR-Reverse Line Blot analysis and traditional culture of dermatophytes in clinical samples INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Resumen congreso2007 Comprehensive view of the haemopoietic stem cell program: The pre-transplant phase HAEMATOLOGICA
Artículo2007 CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors BLOOD
Capítulo2007 Estudio descriptivo de las complicaciones infecciosas de 60 receptores de trasplante alogénico de progenitores hematopoyéticos consecutivos Actualizaciones en trasplantes 2007
Capítulo2007 Evaluación del uso de antifúngicos en receptores de trasplantes de progenitores hematopoyéticos y otros pacientes hematológicos Actualizaciones en trasplantes 2007
Resumen congreso2007 Incidence of neutropenia and hypogammaglobulinemia and correlation with the infections rate in indolent non-Hodgkin lymphoma (NHL) receiving rituximab maintenance BLOOD
Resumen congreso2007 Risk factors for bacteraemia caused by extended-spectrum beta-lactamase producing-Escherichia coli in hospitalized haematological patients HAEMATOLOGICA
Artículo2007 Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Resumen congreso2007 The role of allogeneic stem cell transplantation with reduced-intensity conditioning in patients with chemoresistant malignancies BONE MARROW TRANSPLANTATION
Capítulo2007 Trasplante de progenitores hematopoyéticos de intensidad reducida enpacientes resistentes a terapias convencionales Actualizaciones en trasplantes 2007
Capítulo2007 Trasplantes de progenitores hematopoyéticos de los HH UU Virgen del Rocío en 2006 Actualizaciones en trasplantes 2007
Resumen congreso2006 Autologous stem cell transplantation (ASCT) in HIV associated lymphoma (HIV-Ly) patients: The EBMT lymphoma working party (EBMT-LWP) experience. BLOOD
Letter2006 Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source LEUKEMIA
Resumen congreso2006 Comparative study of autologous stem cell transplant (ASCT) in HIV-1 positive (HIV plus ) on haart and HIV-1 negative (HIV-) non Hodgkin lymphoma (NHL) patients. BLOOD
Resumen congreso2006 Epidemiology of cytomegalovirus in allogeneic haematopoietic stem cell transplant recipients BONE MARROW TRANSPLANTATION
Artículo2006 Evaluation of readmissions in hematopoietic stem cell transplant recipients TRANSPLANTATION PROCEEDINGS
Revisión2006 Hematopoietic stem cell transplantation in systemic autoimmune diseases. State of the art REUMATOLOGIA CLINICA
Resumen congreso2006 Readmissions evaluation in allogeneic haematopoietic stem cell transplant recipients BONE MARROW TRANSPLANTATION
Resumen congreso2005 Cyclosporine and methotrexate immunosuppression based regimen after non-myeloablative haematopoietic stem cell transplantation. Single-centre experience BONE MARROW TRANSPLANTATION
Resumen congreso2005 Does highly active anti-retroviral therapy (HAART) delay myeloid engraftment after autologous stem cell transplant (ASCT) in HIV associated lymphoma (HIV plus Ly) patients? BLOOD
Artículo2005 Hemopoietic stem cell transplantation in childhood: Reduction in mortality and improvement of survival over the years TRANSPLANTATION PROCEEDINGS
Resumen congreso2005 Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease BONE MARROW TRANSPLANTATION
Revisión2005 Tratamiento antifúngico empírico en pacientes seleccionados con fiebre persistente y neutropenia Empirical antifungal therapy in selected patients with persistent fever and neutropenia Enfermedades infecciosas y microbiología clínica
Artículo2004 Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR JOURNAL OF RHEUMATOLOGY
Resumen congreso2004 Efficacy and safety of fludarabine/cyclophosphamide (FC) as front-line treatment of CLL. Final results of a phase II clinical trial in a single center. BLOOD
Artículo2004 Haematopoetic stem cell transplantation for refractory autoimmune cytopenia BRITISH JOURNAL OF HAEMATOLOGY
Artículo2004 HLA-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease TRANSPLANTATION
Resumen congreso2004 HLA-DPB1 mismatch is associated with acute GvHD after HLA-identical sibling donor stem cell transplantation BONE MARROW TRANSPLANTATION
Letter2004 Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation LEUKEMIA
Corrección2004 Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation (vol 18, pg 1031, 2004) LEUKEMIA
Artículo2003 Autotrasplante de progenitores hematopoyéticos en el tratamiento de las enfermedades autoinmunes. Experiencia internacional y española Revista Española de Reumatología
Resumen congreso2003 Efficacy and safety of Fludarabine/Cyclophosphamide (FC) as front-line treatment of CLL. Preliminary results of a phase II clinical trial. BLOOD
Artículo2003 Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation HAEMATOLOGICA
Resumen congreso2003 Hemopoietic stem cell transplantation in childhood: improved survival over the years and reduction of transplant-related mortality in the autologous setting BONE MARROW TRANSPLANTATION
Artículo2003 Hemopoietic stem cell transplantation in refractory rheumatoid arthritis is not a contraindication for reconstructive surgery CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Artículo2003 Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: Preliminary results from the Spanish experience TRANSPLANTATION PROCEEDINGS
Artículo2003 Positive selection for CD34(+) reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation EXPERIMENTAL HEMATOLOGY
Editorial2003 Trasplante de progenitores hemopoyéticos e inducción de tolerancia inmunológica en las enfermedades autoinmunes FARMACIA HOSPITALARIA
Artículo2002 Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors TRANSFUSION
Resumen congreso2002 Chronic graft versus host disease after allogeneic transplantation of CD34+selected cells from peripheral blood from HLA-identical siblings. BLOOD
Ponencia2002 Hematopoietic stem cell transplantation in patients or from donors with hepatitis B or C virus infection: Review and recommendations MEDICINA CLINICA
Editorial2002 Immunosuppression and hematopoietic stem cell transplantation for autoimmune diseases MEDICINA CLINICA
Artículo2002 Inmunoablación y trasplante de progenitores hematopoyéticos en las enfermedades autoinmunes MEDICINA CLINICA
Resumen congreso2002 Phase I/II trials of autologous peripheral blood stem cell transplantation (ASCT) in autoimmune diseases (AID) resistant to conventional therapy: preliminary results of the Spanish experience BONE MARROW TRANSPLANTATION
Resumen congreso2002 Positive selection for CD34+reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. BLOOD
Resumen congreso2002 Risk factors for acute graft-versus-host disease in patients transplanted with CD34+selected blood cells from HLA-identical siblings BONE MARROW TRANSPLANTATION
Artículo2002 Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34(+) selected blood cells from HLA-identical siblings BLOOD
Artículo2002 Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
Resumen congreso2001 Allogeneic peripheral blood stem cell transplantation (allo-PBT): results of 327 patients from the Spanish registry. BONE MARROW TRANSPLANTATION
Artículo2001 Allogeneic transplantation of CD34(+)-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation BONE MARROW TRANSPLANTATION
Letter2001 Autologous stem cell transplantation in a patient with rheumatoid arthritis [4] MEDICINA CLINICA
Artículo2001 Autotrasplante de progenitores hematopoyéticos en una paciente con artritis reumatoide MEDICINA CLINICA
Artículo2001 Donor age-related differences in PBPC mobilization with rHuG-CSF TRANSFUSION
Artículo2001 Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies BRITISH JOURNAL OF HAEMATOLOGY
Artículo2001 Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease ANNALS OF THE RHEUMATIC DISEASES
Resumen congreso2001 Plasma levels of t-PA Ag and D-dimer predict development of veno-occlussive disease of the liver (VOD) in patients undergoing allogeneic stem cell transplant. BLOOD
Artículo2001 The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings BLOOD
Resumen congreso2001 Variables affecting the collection of a CD34+cell dose > 4 x106/kg in healthy donors with one apheresis BONE MARROW TRANSPLANTATION
Resumen congreso2000 Analysis of factors associated with a low peripheral blood progenitor cell (PBPC) collection in normal donors. BLOOD
Resumen congreso2000 Predictive factors for graft versus host disease after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings. BLOOD
Resumen congreso2000 The number of donor CD3+cells is the most important factor for graft failure after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings. BLOOD
Ponencia2000 The number of donor CD34+ and CD3+ cells is the most important factor for disease free survival after allogeneic transplantation of CD34+ selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings Hematology and Cell Therapy
Resumen congreso2000 The number of donor CD34+and CD3+cells is the most important factor for disease free survival (DFS) after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings. BLOOD
Artículo2000 Trasplante autólogo de progenitores hematopoyéticos en las enfermedades autoinmunes Revista Española de Reumatología
Artículo1999 Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry BONE MARROW TRANSPLANTATION
Resumen congreso1999 Allogeneic vs autologous haemopoietic stem cell transplant (HSCT) in acute leukaemia (AL). BONE MARROW TRANSPLANTATION
Resumen congreso1999 Comparative study of filgrastim and lenograstim for peripheral blood stem cell mobilization in healthy donors BONE MARROW TRANSPLANTATION
Resumen congreso1999 Donor age related differences in peripheral blood stem mobilization with recombinant human granulocyte-colony stimulating factor (rhG-CSF). BLOOD
Resumen congreso1999 Evidence of graft-versus-tumor (GVT) effect in 136 patients with advanced hematologic malignancies receiving unmanipulated peripheral blood stem cell allografts (allo-PSCT): The Spanish experience. BLOOD
Resumen congreso1999 Hemostatic and endothelial dammage markers in allogenic and autologous bone marrow transplantation THROMBOSIS AND HAEMOSTASIS
Artículo1999 Prospective, comparative study of different amino acid and lipid solutions in the parenteral nutrition of patients subjected to a bone marrow transplantation NUTRICION HOSPITALARIA
Letter1999 Reactivation of HBV following allogeneic bone marrow transplantation: new approaches Revista Española de Enfermedades Digestivas
Letter1999 Reactivation of HBV following allogeneic bone marrow transplantation: new outlook (the hepatitis B virus and the bone marrow transplant) Revista Española de Enfermedades Digestivas
Revisión1999 Trasplante autólogo de progenitores hematopoyéticos en pacientes con artritis reumatoide resistentes al tratamiento convencional Revista Española de Reumatología
Resumen congreso1998 Allogeneic peripheral blood progenitor cell transplantation (allo-PBT) in 64 patients with advanced hematologic malignancies. BONE MARROW TRANSPLANTATION
Resumen congreso1998 Allogeneic peripheral blood progenitor cells transplantation (allo-PBT) in 64 patients with advanced hematologic malignancies. BONE MARROW TRANSPLANTATION
Resumen congreso1998 Early infections in 163 consecutive autologous hemopoietic progenitor cell transplants. BONE MARROW TRANSPLANTATION
Resumen congreso1998 Effects of granulocyte-colony stimulating factor in normal donors. Results of the Spanish National Donor Registry. BONE MARROW TRANSPLANTATION
Resumen congreso1998 Transplantation with peripheral blood stem cells from unrelated donor in chronic myelocytic leukaemia. BONE MARROW TRANSPLANTATION
Resumen congreso1997 Allogeneic peripheral blood progenitor cells transplantation (allo-PBT) for patients with advanced hematologic malignancies. BLOOD
Artículo1997 Trasplante alogénico de progenitores hemopoyéticos de sangre periférica no manipulados: Experiencia española de 79 casos SANGRE
Artículo1995 Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment BONE MARROW TRANSPLANTATION
Nota1995 REVERSAL OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE BY COMBINED PLASMA-EXCHANGE AND RT-PA TREATMENT BONE MARROW TRANSPLANTATION
Artículo1993 Generation of LAK cells in vitro in patients with acute leukemia LEUKEMIA
Resumen congreso1993 HIGH FLUORESCENCE RETICULOCYTES INCREASE IN PERIPHERAL-BLOOD IS THE FIRST SIGN OF CIRCULATING STEM-CELLS AFTER APLASIA INDUCED CHEMOTHERAPY EXPERIMENTAL HEMATOLOGY
Artículo1992 A fully automated method for mononuclear bone marrow cell concentration Journal of Clinical Apheresis
Artículo1990 PERIPHERAL BLOOD STEM CELL COLLECTION: COMPARISON OF TWO PROTOCOLS BONE MARROW TRANSPLANTATION
Artículo1990 PERIPHERAL-BLOOD STEM-CELL COLLECTION - COMPARISON OF 2 PROTOCOLS BONE MARROW TRANSPLANTATION
Letter1990 Thrombotic thrombocytopenic purpura in a patient with the acquired immunodeficiency syndrome REVISTA CLINICA ESPANOLA
Trasplante autólogo de células germinales hematopoyéticas en hemopatías malignas: Evaluación del procedimiento (1993)
Dirigida por: Juan Manuel Rodríguez Fernández, José Villar Ortiz
Tesis dirigidas/tutorizadas:2
Fecha lectura Título Rol
27/06/2017 EPIDEMIOLOGÍA Y ANÁLISIS GENÉTICO DE LA HEMOFILIA A EN ANDALUCIA Director/a
22/01/2016 Efecto inmunomodulador de la vitamina D en el periodo postrasplante alogénico de progenitores hematopoyéticos Director/a
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado